Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Closes Acquisition of Lab Automation Firm Velocity11

NEW YORK (GenomeWeb News) – Agilent Technologies said last week that it has completed the acquisition of Velocity11, a developer of automated liquid handling and laboratory robotics for the life science market.
 
Financial details of the transaction were not disclosed.
 
Agilent announced its plan to purchase the privately firm last month.
 
The company said that it expects the acquisition to give it “more comprehensive suite of workflow solutions” for the pharmaceutical, biotech, and academic research markets.
 
Agilent said that “substantially all” of Velocity11's 150 employees have joined Agilent.
 
Velocity11 is based in Menlo Park, Calif., and has a second office in Melbourn, UK.
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more